CPIG
ARRY

Chicago Partners Investment Group’s Array Biopharma Inc ARRY Stock Holding History

Chicago Partners Investment Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-550
Closed -$8K – 1062
2018
Q3 		$8K Hold
550
– – ﹤0.01% 868
2018
Q2 		$9K Hold
550
– – ﹤0.01% 830
2018
Q1 		$9K Hold
550
– – ﹤0.01% 797
2017
Q4 		$7K Hold
550
– – ﹤0.01% 796
2017
Q3 		$7K Buy
+550
New +$5.11K ﹤0.01% 842
2017
Q2 		– Sell
-550
Closed -$5K – 840
2017
Q1 		$5K Hold
550
– – ﹤0.01% 499
2016
Q4 		$5K Hold
550
– – ﹤0.01% 469
2016
Q3 		$4K Buy
+550
New +$2.13K ﹤0.01% 470

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Chicago Partners Investment Group's ARRY Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of Array Biopharma Inc (ARRY) in Q4 2018, closing a stake of 550 shares — an estimated $8K sold.

Chicago Partners Investment Group first reported a position in ARRY in Q3 2016 and held it in 8 quarters. The position peaked at $9K in Q2 2018. 236 funds tracked by Wall St. Rank hold ARRY as of Q4 2018.

  • Chicago Partners Investment Group reported no remaining Array Biopharma Inc position as of Q4 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 550 Array Biopharma Inc shares in Q4 2018, an estimated $8K.
  • Chicago Partners Investment Group first reported a position in Array Biopharma Inc in Q3 2016 and held it in 8 quarters.
  • Chicago Partners Investment Group's Array Biopharma Inc position peaked at $9K in Q2 2018.
  • 236 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.